凯雷集团 2025年度报告

S H A R E H O L D E R I N Q U I R I E S Information about Carlyle, including quarterly earnings releasesand filings with the U.S. Securities and Exchange Commission,can be accessed via Carlyle’s website at www.carlyle.com.Shareholder inquiries can also be directed by e-mailto public.investor@carlyle.com. S TO C K E XC H A N G E The common stock of The Carlyle Group Inc. trades on theNasdaq Global Select Market with CG as its ticker symbol. T R A N S F E R AG E N TEquiniti6201 15th AvenueBrooklyn, NY 11219+1 800 937 5449 T R A D E AS S O C I AT I O N American Investment Council799 9th Street, NW, Suite 200Washington, DC 20001+1 202 583 5263 Board of Directors andExecutive Officers DAVID M. RUBENSTEINCO-FOUNDER ANDCO-CHAIRMAN AFSANEH BESCHLOSSDIRECTOR HARVEY M. SCHWARTZCHIEF EXECUTIVE OFFICERAND DIRECTOR DANIEL A. D’ANIELLOCO-FOUNDER ANDCHAIRMAN EMERITUS WILLIAM E. CONWAY, JR.CO-FOUNDER ANDCO-CHAIRMAN LINDA H. FILLERDIRECTOR MARK S. ORDANLEAD INDEPENDENTDIRECTORChairman and Chief ExecutiveOfficer of Pediatrix Medical Group LAWTON W. FITTDIRECTOR SHARDA CHERWOODIRECTORFormer Senior Partner at Ernst& Young LLP JAMES H. HANCE, JR.DIRECTOR Carlyle Operating Executiveand former Vice Chairman ofBank of America Former Executiveof Walgreen Co, Walmart, KraftFoods, and Hanesbrands Former Investment Banker andPartner at Goldman Sachs ANTHONY WELTERSDIRECTOR JEFF NEDELMANCO-PRESIDENT ANDGLOBAL HEAD OF CLIENTBUSINESS DERICA W. RICEDIRECTOR WILLIAM J. SHAWDIRECTOR MARK JENKINSCO-PRESIDENT AND HEADOF GLOBAL CREDIT &INSURANCE Founder, Chairman, and Chief ExecutiveOfficer of CINQ Care Inc. and ExecutiveChairman of BlackIvy Group, LLC Former Executive Vice Presidentof CVS Health and formerPresident of CVS Caremark FormerVice Chairman ofMarriott International Board MemberExecutive Officer JOHN C. REDETTCO-PRESIDENT AND HEAD OFGLOBAL PRIVATE EQUITY JUSTIN V. PLOUFFECHIEF FINANCIAL OFFICER JEFFREY W. FERGUSONGENERAL COUNSEL LINDSAY P. LOBUECHIEF OPERATING OFFICER UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549FORM 10-K (Mark One) (Exact name of registrant as specified in its charter) 1001 Pennsylvania Avenue, NWWashington, DC, 20004-2505(Address of principal executive offices) (Zip Code)(202) 729-5626(Registrant’s telephone number, including area code)Not Applicable(Former name or former address, if changed since last report)Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.YesýNo¨ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filingrequirements for the past 90 days.YesýNo¨ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit suchfiles).YesýNo¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. Seethe definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act Large accelerated filer☒Non-accelerated filer☐ Accelerated filer☐Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared orissued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in thefiling reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation receivedby any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes☐ NoýThe aggregate market value of the common stock of the registrant held by non-affiliates as of June 30, 2025 was $13,579,714,543.T